Is JE vaccination cost effective (module 2)

• Cost-effectiveness analysis is a useful way to compare the costs and benefits of introducing and maintaining JE vaccination with those of not introducing the vaccine. It is an important tool for decision-makers considering JE vaccination programs. • While no cost-effectiveness data are yet available for two of the three WHO-prequalified vaccines, all analyses to-date of the WHO-prequalified CD-JEV vaccine have found JE vaccination to be cost-effective, highly cost-effective, or even cost-saving, despite wide variation in modeled incidence rates and dosing schedules. • If your country has a JE burden, it is likely that JE vaccination will be cost-effective, comparable to other vaccines in childhood immunization schedules. • Because of the wealth of existing data, it is not necessary for every country to conduct their own cost-effectiveness analysis. Instead, you can look at existing studies from countries with a JE burden and characteristics comparable to your own.